Real‐world use of glucocorticoids and clinical outcomes in adults hospitalized with community‐acquired pneumonia on medical wards
Journal of Hospital Medicine · 2024
DOI: 10.1002/jhm.13422 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hospital Medicine, 2024. Verfasst von Sarah Malecki und 10 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Residency Program, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Glucocorticoids, Community-Acquired Infections, Pneumonia, Hospitalization. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Medical Protective Agency, University of Toronto Department of Medicine, Green Shield Canada Foundation.
Abstract (Originalsprache)
Background
Little is known about the real‐world use of systemic glucocorticoids to treat patients hospitalized with community‐acquired pneumonia (CAP) outside of the intensive care unit (ICU).
Methods
This retrospective cohort study included 11,588 hospitalizations for CAP without chronic pulmonary disease at seven hospitals in Ontario, Canada. We report physician‐level variation in the use of glucocorticoids and trends over time. We investigated the association between glucocorticoid prescriptions and clinical outcomes, using propensity score overlap weighting to account for confounding by indication.
Results
Glucocorticoids were prescribed in 1283 (11.1%) patients, increasing over time from 10.0% in 2010 to 11.9% in 2020 ( p = .008). Physician glucocorticoid prescribing ranged from 2.9% to 34.6% (median 10.0%, inter quartile range [IQR]: 6.7%–14.6%). Patients receiving glucocorticoids tended to be younger (median age 73 vs. 79), have higher Charlson comorbidity scores (score of 2 or more: 42.4% vs. 31.0%), more cancer (26.6% vs. 13.2%), more renal disease (11.5% vs. 6.6%), and less dementia (7.8% vs. 14.8%). Patients treated with glucocorticoids had higher rates of in‐hospital mortality (weighted Risk Difference = 1.72, 95% confidence interval [95% CI]: 0.16–3.3, p = .033). Glucocorticoid use was not associated with ICU admission, hospital length‐of‐stay, or 30‐day readmission.
Conclusion
Glucocorticoids were prescribed in 11.1% of patients hospitalized with CAP outside of ICU and one in four physicians prescribed glucocorticoids in more than 14% of patients. Glucocorticoid use was associated with greater in‐hospital mortality, although these findings are limited by large selection effects. Clinicians should exercise caution in prescribing glucocorticoids for nonsevere CAP, and definitive trials are needed in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Internal Medicine Residency Program, University of Toronto, Toronto, Ontario, Canada.
- Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
- Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Ontario, Canada.
- The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
- Department of Medicine, University of Toronto, Toronto, Canada.
- Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.
ORCID-Profile: Sarah Malecki, Amol A Verma
Förderung
- Canadian Medical Protective Agency
- University of Toronto Department of Medicine
- Green Shield Canada Foundation
- Canadian Cancer Society
- Saint Michael's Hospital Association Innovation Fund
- Natural Sciences and Engineering Research Council of Canada
- Ontario Health
- Canadian Frailty Network
Zitieren
APA
Malecki, S., Loffler, A., Liao, F., Hora, T., Agarwal, A., Lail, S., Roberts, S. B., McFadden, D., Gupta, S., Razak, F., & Verma, A. A. (2024). Real‐world use of glucocorticoids and clinical outcomes in adults hospitalized with community‐acquired pneumonia on medical wards. Journal of Hospital Medicine. https://doi.org/10.1002/jhm.13422
Vancouver
Malecki S, Loffler A, Liao F, Hora T, Agarwal A, Lail S, et al. Real‐world use of glucocorticoids and clinical outcomes in adults hospitalized with community‐acquired pneumonia on medical wards. Journal of Hospital Medicine. 2024. doi:10.1002/jhm.13422
BibTeX
@article{Malecki2024,
author = {Malecki, Sarah and Loffler, Anne and Liao, Fangming and Hora, Tejasvi and Agarwal, Arnav and Lail, Sharan and Roberts, Surain B and McFadden, Derek and Gupta, Samir and Razak, Fahad and Verma, Amol A},
title = {Real‐world use of glucocorticoids and clinical outcomes in adults hospitalized with community‐acquired pneumonia on medical wards},
journal = {Journal of Hospital Medicine},
year = {2024},
doi = {10.1002/jhm.13422}
}
EUVIMED